Search Tag: Personalised Medicine

2024 08 Feb

  Precision cancer therapies represent a promising frontier in the fight against cancer, offering tailored treatments based on individual patient characteristics. However, a bottleneck in regulatory approval processes is hindering the translation of these advances into patient care. This delay has raised concerns among patients who perceive regulators...Read more

2024 08 Feb

  Precision cancer therapies represent a promising frontier in the fight against cancer, offering tailored treatments based on individual patient characteristics. However, a bottleneck in regulatory approval processes is hindering the translation of these advances into patient care. This delay has raised concerns among patients who perceive regulators...Read more

2022 01 Mar

Innovative  rhPSMA Theranostic technology  has the potential to offer both diagnostic imaging and treatment for patients affected by prostate cancer.  Blue Earth Therapeutics  has exclusive worldwide rights to therapeutic applications of radiohybrid Prostate-Specific Membrane Antigen (rhPSMA) radiopharmaceutical technology. “ We are increasingly...Read more

2022 04 Feb

When Inspire2Live organised its first Annual Congress in 2011, José Baselga was one of the speakers, and he opened his speech with the following statement: “We are not meant to be here for 1- or 2-months’ life extension. We can do better!” It was a powerful statement for patients and oncology researchers alike. For patients, because we all...Read more

2020 14 Sep

POSTPONED DUE TO COVID-19 HEALTH CONCERNS FROM JUNE TO 14-18 SEPTEMBER, 2020 AND WILL NOW TAKE PLACE ENTIRELY IN A "VIRTUAL" SETTING Find EHD on Social Media Read more

2019 30 Jul

Researchers from the Dana-Farber Cancer Institute have developed an artificial intelligence (AI) tool which is just as effective as their human counterparts in gathering information on cancer progression from unstructured radiology reports. The study published in JAMA Oncology showed how AI could not only distinguish cancer presence and the outcomes...Read more

2017 19 Sep

Comparing radiology to living at or near the ocean allows the threats to radiology to be explored via a nautical theme.   Our specialty is heading for a period of uncertainty, disquiet, challenge and perhaps peril, one that will likely manifest itself in the medium term, five to fifteen years hence at the latest. The signs that should engender...Read more

2017 16 Mar

The specialty of intensive care medicine grew out of the realisation that critically ill patients needed more attention and specialised treatment than could be provided on a general ward, and that many of these patients had similar clinical problems and processes, so management would be facilitated if they were grouped together in one place. Since...Read more

2017 16 Mar

Peter Pronovost, MD, PhD, FCCM, is Director, Armstrong Institute for Patient Safety and Quality, Senior Vice President, Patient Safety and Quality and Professor of Anesthesiology and Critical Care Medicine at Johns Hopkins Medicine in Baltimore, Maryland, USA. Dr. Pronovost is a leading authority on patient safety and developed a scientifically...Read more